"We are the leading provider of eye care in the Inland Empire. The goal of our department is to excel in the areas of patient care, physician education, and clinical research in opthalmology. At the Loma Linda University Eye Institute, cutting edge technology and innovative surgical techniques are used to serve our patients within a Christian environment"

During the past decade, Loma Linda University Health Care, Dept. of Ophthalmology conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 13 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 8 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Loma Linda University Health Care, Dept. of Ophthalmology" #1 sponsor was "Jaeb Center for Health Research" with 19 trials, followed by "Pfizer" with 2 trials sponsored, "Claris Biotherapeutics, Inc." with 1 trials sponsored, "Dompé Farmaceutici S.p.A" with 1 trials sponsored and "Loma Linda University" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Loma Linda University Health Care, Dept. of Ophthalmology" #1 collaborator was "National Eye Institute (NEI)" with 18 trials as a collaborator, "Genentech, Inc." with 5 trials as a collaborator, "Allergan" with 4 trials as a collaborator, "National Institutes of Health (NIH)" with 4 trials as a collaborator and "Regeneron Pharmaceuticals" with 4 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Loma Linda University Health Care, Dept. of Ophthalmology" are "Diabetic Macular Edema" (11 trials), "Diabetic Retinopathy" (6 trials), "Proliferative Diabetic Retinopathy" (4 trials), "Amblyopia" (2 trials) and "Juvenile Idiopathic Arthritis" (2 trials). Many other conditions were trialed in "Loma Linda University Health Care, Dept. of Ophthalmology" in a lesser frequency.

Most popular intervention types in "Loma Linda University Health Care, Dept. of Ophthalmology" are "Drug" (20 trials), "Other" (7 trials), "Procedure" (7 trials), "Behavioral" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Deferred aflibercept" (2 trials), "Deferred laser" (2 trials), "Placebo" (2 trials), "Prompt aflibercept" (2 trials) and "Ranibizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Loma Linda University Health Care, Dept. of Ophthalmology" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Loma Linda University Health Care, Dept. of Ophthalmology". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Loma Linda University Health Care, Dept. of Ophthalmology, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Loma Linda University Health Care, Dept. of Ophthalmology, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".